Winter Flops, Summe...
Health Care: Drugs
Cerus Corporation (CERS: NASDAQ)
$4.40 -0.15 | -3.30%
06/19/13 - 04:00 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -15.92M | -16.98M | -16.91M | -24.14M |
| Operating Gains/Losses | 0.00 | -114.00K | -252.00K | -1.49M |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 1.65M | -1.30M | -1.17M | 696.00K |
| (Increase) Decrease in Inventories | -3.74M | -487.00K | 2.02M | 3.37M |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | 2.51M | 1.45M | -1.19M | 102.00K |
| (Decrease) Increase In Other Current Liabilities | 1.97M | -336.00K | 604.00K | 1.46M |
| (Increase) Decrease In Other Working Capital | -1.70M | -150.00K | 2.00K | 45.00K |
| Other Non-Cash Items | 502.00K | 1.37M | 1.94M | 4.38M |
| Net Cash From Continuing Operations | -13.92M | -15.63M | -14.11M | -14.66M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -13.92M | -15.63M | -14.11M | -14.66M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 0.00 | 10.13M |
| Purchases of Property, Plant & Equipment | -81.00K | -158.00K | -1.71M | -191.00K |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | -499.00K |
| Other Cash from Investing Activities | -1.00K | 55.00K | -11.00K | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | 205.00K | 563.00K | -87.00K | 9.44M |
| Issuance of Debt | 1.81M | 7.21M | 4.88M | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 14.56M | 9.42M | 19.66M | 78.00K |
| Repayment of Long-Term Debt | -1.46M | -5.01M | -34.00K | -5.00K |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 0.00 | 0.00 | 1.35M | 12.14M |
| Net Cash From Financing Activities | 14.91M | 11.62M | 25.86M | 12.21M |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | 1.20M | -3.45M | 11.66M | 6.98M |
Portfolios with CERS
- Portfolio NameUser Type
- ContributorBreakout Stocks Of The Week...
- ContributorBreakout Stocks Of The Week...
- UserRASHID 1
- Contributor5 Bargain Biotech Stocks
- UserImagine!
- UserSUPRATRADE - 8 Hot Stocks t...
- UserShake & Bakkke
- Sharespy
- Usermoneymag7 Portfolio 1
- Useriornhorse
Latest CERS Headlines from TheStreet
- 5 Stocks Poised for Breakouts 09.28.12 | 01:09 pm
- 5 Stocks Poised for Breakouts 07.13.12 | 12:07 pm
- Insiders Trading CERS, IL, MDCA, UA 05.09.11 | 08:05 am
- Cerus Stock Gaps Down On Today's Open (CERS) 03.04.11 | 09:03 am
- 5 Bargain Biotech Stocks 01.13.11 | 05:01 pm
- Jones Soda, Callon Petroleum: Early Volume Plays 03.09.10 | 09:03 am
- China BAK, Euro Tech: Early Volume Plays 02.09.10 | 10:02 am
- Biotech Stock Mailbag: FDA Playbook 11.20.09 | 06:11 am
- Playboy, Helicos: Early Volume Plays 11.17.09 | 09:11 am
- Friday's Health Winners & Losers 05.02.08 | 03:05 pm
Press Releases for CERS
- Cerus Signs INTERCEPT Platelet Agreements With Two Key Blood Component Suppliers In Germany And Austria - Business Wire 03.15.13 | 08:03 am
- Cerus Prices Public Offering Of Common Stock - Business Wire 03.14.13 | 09:03 am
- Cerus Corporation Reports Fourth Quarter And Year-End 2012 Results - Business Wire 02.28.13 | 04:02 pm
- Cerus To Present At The Cowen And Company 33rd Annual Health Care Conference On March 6, 2013 - Business Wire 02.27.13 | 08:02 am
- Cerus To Release Fourth Quarter And Year-End 2012 Results On February 28, 2013 - Business Wire 02.14.13 | 08:02 am
- Cerus Announces FDA Agreement On Modular Premarket Approval Application (PMA) Submission Process For INTERCEPT Plasma - Business Wire 12.13.12 | 08:12 am
- Cerus Signs Agreement With Swiss Red Cross For Initial Deployment Of The INTERCEPT Blood System For Plasma - Business Wire 12.04.12 | 08:12 am
- Cerus To Present At The Piper Jaffray Healthcare Conference On November 28, 2012 - Business Wire 11.21.12 | 08:11 am
- Cerus To Present At The Stephens Fall Investment Conference On November 14, 2012 - Business Wire 11.08.12 | 09:11 am
- Cerus To Present At The Lazard Capital Markets 9th Annual Healthcare Conference On November 14, 2012 - Business Wire 11.08.12 | 08:11 am
Partner Headlines for CERS
- After Hours Most Active for Mar 1, 2013 : CERS, SIRI, ABT, SBGL, ABBV, VOD, BAC, NOK, QQQ, AMD, INTC, HOLX - NASDAQ 03.01.13 | 09:03 pm
- Low-Priced Biotech Stocks With Insider Buying - Seeking Alpha 03.18.11 | 06:03 pm
- Company News for March 07, 2011 - Corporate Summary - Zacks 03.07.11 | 10:03 am
- UPDATE 1-Cerus to regain Asian rights for blood safety system - Reuters 08.24.10 | 05:08 pm
- Cerus: An Unknown Gem That's Primed for a Boost - Seeking Alpha 05.18.10 | 02:05 pm
- Tengion's IPO Comes In Well Below Initial Range: Biotech's Latest Deals, Financings - SeekingAlpha.com 04.11.10 | 08:04 am
- The Return of Buy and Hold? - SeekingAlpha.com 04.06.10 | 10:04 am
- 25 Momentum Stocks for Tuesday - SeekingAlpha.com 04.06.10 | 03:04 am
- Weekly Street Sentiment: Market Continues Up, But Sell-Side Sentiment Eases Lower Again - SeekingAlpha.com 04.05.10 | 12:04 am
- UPDATE 1-Cerus in development deal for blood safety system - Reuters 02.09.10 | 01:02 pm
